SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
VectivBio Holding AG (VECT) .
Criteria proven by this page:
- VALUE (60/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
- Analyst consensus target $18.00 (+6.7% upside) — modest upside expected.
Overall SharesGrow Score: 43/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — VECT
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio27.23
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-2.12
Book Value / Share$0.00
Revenue / Share$0.62
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$18.00 (+6.7%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-1.01 |
$0.00 |
$-23.53M |
- |
| 2020 |
$-6.30 |
$0.00 |
$-60.5M |
- |
| 2021 |
$-3.23 |
$0.00 |
$-87.01M |
- |
| 2022 |
$-2.12 |
$27.34M |
$-93.74M |
-342.8% |
